Delix Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Delix Therapeutics's estimated annual revenue is currently $7M per year.
- Delix Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Delix Therapeutics has 45 Employees.
- Delix Therapeutics grew their employee count by 32% last year.
Delix Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Toxicology and DMPK | Reveal Email/Phone |
2 | VP - Chemistry, Manufacturing and Controls (CMC) | Reveal Email/Phone |
3 | Interim VP Operations | Reveal Email/Phone |
4 | Senior Director Pharmacology | Reveal Email/Phone |
5 | Senior Director, Neuroplasticity | Reveal Email/Phone |
6 | Associate Director, Pharmacology | Reveal Email/Phone |
7 | Senior Director Medicinal Chemistry | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Associate Director | Reveal Email/Phone |
10 | Chief People Officer (CPO) | Reveal Email/Phone |
Delix Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Delix Therapeutics?
N/A
Total Funding
45
Number of Employees
$7M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Delix Therapeutics News
2022-04-17 - Wellness: Ketamine
It works for substance abuse, PTSD and depression. But it's not a panacea. They just target the prefrontal cortex. Delix Therapeutics was...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.8M | 45 | 25% | N/A |
#2 | $6.2M | 45 | 25% | N/A |
#3 | $5.2M | 45 | 7% | N/A |
#4 | $5.2M | 45 | 36% | N/A |
#5 | $7.5M | 45 | 15% | N/A |